MENU
DMAC
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

DiaMedica Therapeutics (DMAC) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

DMAC is expected to report earnings to rise 19.23% to -15 cents per share on November 06

DiaMedica Therapeutics DMAC Stock Earnings Reports
Q3'24
Est.
$-0.16
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.02
Q3'23
Beat
by $0.01
The last earnings report on August 07 showed earnings per share of -12 cents, beating the estimate of -15 cents. With 24.95K shares outstanding, the current market capitalization sits at 178.69M.
View a ticker or compare two or three
DMAC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
19
Web
https://www.diamedica.com